Oct 3 2013
Biophotonic Solutions Inc. (BSI), the world leader in automated laser pulse compression, has closed a one-million-dollar Series A funding round led by the Michigan Angel Fund.
"The Series A capital shores up BSI's resources so that we can aggressively pursue OEM business in microscopy, semiconductor processing, and the development of cost-effective ultrafast lasers with adaptive capabilities," said Kiyomi Monro, BSI CEO. "We look forward to complementing our established business, which is enabling femtosecond laser breakthroughs at leading universities, with new commercial opportunities."
Typically used for scientific research, ultrafast lasers producing pulses in the multi-femtosecond range offer significant advantages for many commercial applications. However, currently these lasers are expensive, challenging to implement, and demand manual tweaking from a laser expert to fine-tune their output. BSI's proprietary technology, called "MIIPS," provides automated measurement and compression of ultrafast laser pulses, automatically delivering optimized laser light to the target. Thanks to this new level of autonomous laser output consistency and ease of use, MIIPS technology may ultimately enable scalable and cost-effective femtosecond laser deployment in a wide range of industrial and medical settings.
About Biophotonic Solutions Inc.
Biophotonic Solutions Inc. is the world leader in automated, adaptive femtosecond laser pulse compression and temporal shaping. BSI develops, licenses, and sells cost-effective solutions that drive the ultimate performance from lasers for high-precision imaging, material processing, and other applications where transform-limited ultrafast pulses are desirable at the focal plane. BSI's products, based on exclusively licensed technology, unlock the latent power of ultrafast lasers for industrial, scientific, medical, and defense applications.
Press release avilable from http://www.marketwired.com/
Source: http://www.biophotonicsolutions.com